EyePoint Pharmaceuticals (EYPT) Net Cash Flow: 2010-2024
Historic Net Cash Flow for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to -$181.6 million.
- EyePoint Pharmaceuticals' Net Cash Flow rose 24.04% to -$27.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$49.0 million, marking a year-over-year decrease of 591.66%. This contributed to the annual value of -$181.6 million for FY2024, which is 197.81% down from last year.
- EyePoint Pharmaceuticals' Net Cash Flow amounted to -$181.6 million in FY2024, which was down 197.81% from $185.6 million recorded in FY2023.
- EyePoint Pharmaceuticals' Net Cash Flow's 5-year high stood at $185.6 million during FY2023, with a 5-year trough of -$181.6 million in FY2024.
- In the last 3 years, EyePoint Pharmaceuticals' Net Cash Flow had a median value of -$83.0 million in 2022 and averaged -$26.3 million.
- Per our database at Business Quant, EyePoint Pharmaceuticals' Net Cash Flow soared by 489.05% in 2021 and then tumbled by 197.81% in 2024.
- Over the past 5 years, EyePoint Pharmaceuticals' Net Cash Flow (Yearly) stood at $22.7 million in 2020, then spiked by 489.05% to $133.7 million in 2021, then plummeted by 162.06% to -$83.0 million in 2022, then surged by 323.76% to $185.6 million in 2023, then plummeted by 197.81% to -$181.6 million in 2024.